Skip to content
Review Open access

NLRP3 Inflammasome in Psoriasis: Role in Disease Pathogenesis, Biomarker Potentiality and Therapeutic Targeting

Oct 2026 · International Journal of Drug Delivery Technology · 0 citations

Abstract

From an immunological perspective, the term NLRP3 is widely regarded as a critical regulator of immune system dysregulation. The NLRP3 Inflammasome, is basically a complex unit made up of multiple proteins and plays an essential role towards controlling inflammatory signals and the innate immune system. Specifically, proinflammatory cytokines. This review provides an overview of the activation process of the NLRP3 inflammasome and the story about the role of this inflammasome in psoriasis and other psoriasis-related immune-systemmediated skin disorders. NLRP3 oligomerisation starts in response to pathogen associated molecular pattern PAMPs and DAMPs, which further triggers caspase-1 and activates caspase-1, which releases mature IL-18 and IL-1β. The activation of inflammatory reactions is caused by vast intracellular multi-protein signaling complexes called inflammasomes. NLRP3, comes in the group of inflammasomes, has been linked to a number of inflammatory and other autoimmune skin disorders, such as acne, bullous pemphigoid, dermatophytosis, urticaria and other skin problems. Oligomerization of NLRP3 activates caspase-1 by being activated by PAMPs and DAMPs, which kickstarts the process of cleaving and then releasing IL-1β, IL-18. Focusing on this inflammasome and targeting it’s downstream signals will yield fresh insights into the creation of future treatment approaches.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.